Analyses of drug markets over many years have shown that the price and purity of illicit substances can have a key role in shaping drug consumption, and in turn drug-related harm.
Retaining patients in buprenorphine treatment is essential in maximising treatment outcomes and minimising mortality risk. Delivery of treatment via novel depot buprenorphine products has the potential to enhance patient adherence and retention in treatment.
This project will provide an international literature review of the approaches taken in Ireland and other jurisdictions to simple possession drug offences.
This PhD project will examine untreated remission from alcohol problems. This will involve understanding the way in which those with alcohol problems engage in ‘spontaneous remission’ or ‘natural recovery’ outside the treatment setting.
In 2016 the ACT committed to scoping and designing a Drug and Alcohol Court (DAC).
This is a PhD project of Vivienne Moxham-Hall (supervised by Professor Alison Ritter and Dr Caitlin Hughes) investigating the utility of indexes as a measure of drug policy.
This is the PhD project of Ms Shann Hulme.
National and international evidence indicates that the non-medical use of pharmaceutical drugs is increasing, along with the associated health, social and economic harms.
Over the past few years, there has been a significant increase in the number of seizures and unintentional overdose fatalities related to illicit synthetic opioids in multiple states across the U.S.
This project attempts to understand the global epidemiology of infectious disease among prisoners in all countries.
The Australian National Advisory Council on Alcohol and Drugs (ANACAD) has funded NDARC to conduct a feasibility study for an early warning system (EWS) project, involving a data collection model that allows rapid triangulation of existing data to provide an early warning and current assessment o